Intracranial pressure (ICP) monitoring is crucial in diagnosing and treating neurological diseases such as subarachnoid and intracerebral hemorrhage, ischemic stroke, hydrocephalus, and meningitis/encephalitis. Bleeding in the brain, tumor, stroke, aneurysm, high blood pressure, or brain infection can lead to fluctuations in intracranial pressure. High ICP can cause headaches, blurred vision, vomiting, and other serious complications such as seizures, neurological damage, and death. According to the Asia Pacific Stroke Fact Sheet 2022, over 7.6 million new ischemic stroke cases are reported yearly, and over 62% of all incident strokes are ischemic strokes. Around 11% of all ischemic stroke cases occur in patients aged 15–49 years, and more than 58% occur in people under 70. Also, 55% of all ischemic stroke cases occur in women and 45% in men. Thus, the increasing prevalence of neurological diseases drives the growth of the Asia Pacific intracranial pressure (ICP) monitoring devices market.
The Asia Pacific intracranial pressure (ICP) monitoring devices market is segmented into Australia, China, India, Japan, South Korea, and the Rest of Asia Pacific. The market in the region is growing at a significant rate and is expected to witness a notable growth during the forecast period owing to factors such as rising geriatric population, growing demand for minimally invasive procedures, rising awareness campaigns, and increasing incidence of neurological disorders. Moreover, the increase in number of research studies and surge in healthcare expenditure are expected to fuel the regional market growth during the forecast period.
Asia Pacific Intracranial Pressure Monitoring Devices Market Segmentation
The Asia Pacific intracranial pressure monitoring devices market is segmented into offering, type, application, end user, and country.
Based on offering, the Asia Pacific intracranial pressure monitoring devices market is segmented into product & systems, solutions & platform, and services. The products & systems segment held the largest share of the Asia Pacific intracranial pressure monitoring devices market in 2023.
Based on type, the Asia Pacific intracranial pressure monitoring devices market is segmented into invasive and non-invasive. The invasive segment held a larger share of the Asia Pacific intracranial pressure monitoring devices market in 2023.
Based on application, the Asia Pacific intracranial pressure monitoring devices market is segmented into traumatic brain injuries, Reye’s syndrome, non-traumatic bleeds, hydrocephalus, space-occupying lesions, cerebral oedema, and others. The traumatic brain injuries segment held the largest share of the Asia Pacific intracranial pressure monitoring devices market in 2023.
Based on end user, the Asia Pacific intracranial pressure monitoring devices market is segmented into hospitals, clinics, ambulatory surgical centers, and others. The hospitals segment held the largest of the Asia Pacific intracranial pressure monitoring devices market in 2023.
Based on country, the Asia Pacific intracranial pressure monitoring devices market is segmented into China, Japan, India, Australia, South korea, and the Rest of Asia Pacific. China dominated the Asia Pacific intracranial pressure monitoring devices market in 2023.
RAUMEDIC AG, Integra LifeSciences Holdings Corp, Medtronic Plc, and NovaSignal Corp are among the leading companies operating in the intracranial pressure monitoring devices market in Asia Pacific.
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ 281.53 Million |
| Market Size by 2028 | US$ 421.54 Million |
| CAGR (2023 - 2028) | 8.4% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2028 |
| Segments Covered |
By Offering
|
| Regions and Countries Covered |
Asia-Pacific
|
| Market leaders and key company profiles |
|
The Asia Pacific Intracranial Pressure Monitoring Devices Market is valued at US$ 281.53 Million in 2023, it is projected to reach US$ 421.54 Million by 2028.
As per our report Asia Pacific Intracranial Pressure Monitoring Devices Market, the market size is valued at US$ 281.53 Million in 2023, projecting it to reach US$ 421.54 Million by 2028. This translates to a CAGR of approximately 8.4% during the forecast period.
The Asia Pacific Intracranial Pressure Monitoring Devices Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Intracranial Pressure Monitoring Devices Market report:
The Asia Pacific Intracranial Pressure Monitoring Devices Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Asia Pacific Intracranial Pressure Monitoring Devices Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Asia Pacific Intracranial Pressure Monitoring Devices Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Asia Pacific Intracranial Pressure Monitoring Devices Market
